Cardiology

Optimizing Patient Outcomes in the Era of PCSK9 Inhibitor Therapeutics
http://academiccme.com/wp-content/uploads/2017/06/910713-125-x-125-wpcf_80x80.jpg
This activity will focus on the most current clinical trial data for optimizing patient outcomes in the era of PCSK9 inhibitor therapeutics presented as an Industry-Supported Symposium at the National Lipid Association 2017 Scientific Sessions…
Webcast
Developing Optimized Treatment Plans for Patients with Dyslipidemia in the Era of PCSK9 Inhibitor Therapeutics
http://academiccme.com/wp-content/uploads/2017/06/FH-125-x-125-wpcf_80x80.jpg
This educational content was derived from the American College of Physicians Internal Medicine Meeting 2017 in San Diego, California…
Webcast
ACC 2017: A Therapeutic Update to Reduce Risk and Optimize Outcomes for Patients with Reduced or Preserved Ejection Fraction Heart Failure
http://academiccme.com/wp-content/uploads/2017/05/910710-125-x-125-wpcf_80x80.jpg
This Official Elsevier Clinical Perspectives and Analysis will cover data presented at the American College of Cardiology 66th Annual Scientific Sessions and Expo held in Washington, DC…
Meeting Reporter
The Role of PCSK9 Inhibitors in Managing Patients With Familial Hypercholesterolemia
http://academiccme.com/wp-content/uploads/2017/03/FH-125-x-125-copy-wpcf_80x80.jpg
This CME activity will focus on the management of patients with familial hypercholesterolemia and the role of PCSK9 inhibitors in this therapeutic area…
Webcast, Downloadable Transcript
AHA 2016: An Update of Emerging Therapeutics to Prevent Stroke in Patients with Non-Valvular Atrial Fibrillation
http://academiccme.com/wp-content/uploads/2017/01/910677-125-x-125-wpcf_80x80.jpg
This Official Elsevier Meeting Reporter will highlight recent science and clinical strategies for the management of patients with atrial fibrillation presented at the American Heart Association Scientific Sessions 2016 held in Orlando, Florida…
Meeting Reporter, Downloadable PDF